45
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Natural Killer Cell Activity, Lymphocyte Proliferation, and Cytokine Profile in Tumor‐Bearing Mice Treated with MAPA, a Magnesium Aggregated Polymer from Aspergillus oryzae

, & , Ph.D.
Pages 305-319 | Published online: 09 Feb 2003
 

Abstract

The present study examined the effects of MAPA, an antitumor aggregated polymer of protein magnesium ammonium phospholinoleate‐palmitoleate anhydride, isolated from Aspergillus oryzae, on concanavalin A (Con A)‐induced spleen cell proliferation, cytokine production and on natural killer (NK) cell activity in Ehrlich ascites tumor‐bearing mice. The Ehrlich ascites tumor (EAT) growth led to diminished mitogen‐induced expansion of spleen cell populations and total NK activity. This was accompanied by striking spleen enlargement, with a marked increase in total cell counts. Moreover, a substantial enhancement in IL‐10 levels, paralleled by a significant decrease in IL‐2 was observed, while production of IL‐4 and interferon‐γ (IFN‐γ) was not altered. Treatment of mice with 5 mg/kg MAPA for 7 days promoted spleen cell proliferation, IL‐2 production and NK cell activity regardless of tumor outgrowth. In addition, MAPA treatment markedly enhanced IFN‐γ levels and reduced IL‐10 production relative to EAT mice. A 35% reduction in splenomegaly with normal number of nucleated cells was also found. Altogether, our results suggest that MAPA directly and/or indirectly modulates immune cell activity, and probably disengages tumor‐induced suppression of these responses. Clearly, MAPA has an impact and may delay tumor outgrowth through immunotherapeutic mechanisms.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.